Search - tctmd.com

Displaying 861 - 880 of 1624

Sort: Relevancy | Date

Presentation NY Valves 2024

A Clinical Approach to Genetics in Hypertrophic Cardiomyopathy

Presenter: Martin Maron

June 07, 2024

Presentation NY Valves 2024

PRO: The Left Atrial Appendage Is the Devil’s Playground – We Should Close Them All!

Presenter: Saibal Kar

June 07, 2024

Presentation NY Valves 2024

Atrial Fibrillation and Left Atrial Appendage Closure (Occlusion): The Gap Between Prevalence and Penetrance

Presenter: Vivek Y. Reddy

June 07, 2024

Presentation NY Valves 2024

When to Consider the Ross and Mitral Reconstruction?

Presenter: Ismail El-Hamamsy

June 07, 2024

Double Valve Reconstruction – Keys to Success

Presentation NY Valves 2024

Double Valve Surgery– Keys to Success

Presenter: Percy Boateng

June 07, 2024

Presentation NY Valves 2024

Mitral Valve Reconstruction in Connective Tissue Syndromes

Presenter: Ahmed El-Eshmawi

June 07, 2024

Presentation NY Valves 2024

Mitral Annular Calcification: A Management Challenge and Potential Strategies

Presenter: Mackram F. Eleid

June 07, 2024

Presentation NY Valves 2024

Understanding the Genetics and Classification of Connective Tissue Syndromes

Presenter: Amy Kontorovich

June 07, 2024

Presentation NY Valves 2024

Anatomy for Tricuspid Interventions: "Live" from the OR

Presenter: Isaac George

June 07, 2024

Presentation NY Valves 2024

What’s Next? Managing the Disease and Advanced Training

Presenter: Charles J. Davidson

June 07, 2024

Presentation NY Valves 2024

Why We Need a "Toolbox" Approach for the Tricuspid Valve

Presenter: Georg Nickenig

June 07, 2024

Presentation NY Valves 2024

Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications?

Presenter: Brian K. Whisenant

June 07, 2024

Presentation NY Valves 2024

Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?

Presenter: Susheel K. Kodali

June 07, 2024

Presentation NY Valves 2024

The Compelling Case for Transcatheter Tricuspid Therapies

Presenter: Philipp Lurz

June 07, 2024

Presentation NY Valves 2024

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

Presenter: Tsuyoshi Kaneko

June 07, 2024

Presentation NY Valves 2024

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Helge Möllmann

June 07, 2024

Presentation NY Valves 2024

Ongoing Research Clinical Research – Impact on Future Guidelines?

Presenter: Dimosthenis Pandis

June 07, 2024

Presentation NY Valves 2024

Case-based Treatment of a Patient With Dyspnea and Increasing Transvalvular Gradients

Presenter: Nino Mihatov

June 07, 2024

Presentation NY Valves 2024

Case-in-Box - TOPAZ Transcatheter Tricuspid Valve Replacement

Presenter: Jörg Hausleiter

June 07, 2024

Presentation NY Valves 2024

What Is the Future of Percutaneous Tricuspid Valve Procedures?

Presenter: Eric Horlick

June 07, 2024

Advertisement

A Clinical Approach to Genetics in Hypertrophic Cardiomyopathy

PRO: The Left Atrial Appendage Is the Devil’s Playground – We Should Close Them All!

Atrial Fibrillation and Left Atrial Appendage Closure (Occlusion): The Gap Between Prevalence and Penetrance

When to Consider the Ross and Mitral Reconstruction?

Double Valve Surgery– Keys to Success

Mitral Valve Reconstruction in Connective Tissue Syndromes

Mitral Annular Calcification: A Management Challenge and Potential Strategies

Understanding the Genetics and Classification of Connective Tissue Syndromes

Anatomy for Tricuspid Interventions: "Live" from the OR

What’s Next? Managing the Disease and Advanced Training

Why We Need a "Toolbox" Approach for the Tricuspid Valve

Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications?

Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?

The Compelling Case for Transcatheter Tricuspid Therapies

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Ongoing Research Clinical Research – Impact on Future Guidelines?

Case-based Treatment of a Patient With Dyspnea and Increasing Transvalvular Gradients

Case-in-Box - TOPAZ Transcatheter Tricuspid Valve Replacement

What Is the Future of Percutaneous Tricuspid Valve Procedures?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content